COMMUNIQUÉS West-GlobeNewswire

Ambu A/S: Major shareholder announcement

05/09/2018 - 14:30

In reference to § 30 and according to § 38 of the Danish Capital Markets Act (Kapitalmarkedsloven), Ambu hereby announces to have received a major shareholder announcement from Chr. Augustinus Fabrikker Akts. On 5 [...]

American College of Rheumatology Releases First-Ever Rheumatic Disease Report Card

05/09/2018 - 14:30

New Report Examines Access, Affordability and Lifestyle Factors Affecting Rheumatic Disease Care in all 50 States and the District of Columbia Atlanta, Sept. 05, 2018 (GLOBE NEWSWIRE) -- The American College of [...]

PSIQ Plans to Become a Fully Reporting SEC Issuer and Uplist to the OTCQB

05/09/2018 - 14:30

SUNRISE, Fla., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that Daszcal Bolton, LLP, an independent certified public accountant has completed the audit of PSIQ’s financial [...]

Zosano Pharma and Collaborators to Present Efficacy Data for M207 in the Treatment of Migraine at the 17th Biennial Migraine Trust International Symposium (MTIS)

05/09/2018 - 14:30

FREMONT, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Anchiano Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference

05/09/2018 - 14:30

CAMBRIDGE, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics ( TASE: ANCN ), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]

Bespoke Extracts Announces Launch of Wholesale CBD Division, Among Other Key Marketing and Business Developments

05/09/2018 - 14:30

SUNNY ISLES, Fla., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD products, today announced the launch of its newly formed Wholesale [...]

Diversicare Announces Appointment of Kerry D. Massey Executive Vice President and Chief Financial Officer

05/09/2018 - 14:30

BRENTWOOD, Tenn., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) today announced the appointment of Kerry D. Massey as the Company’s Executive Vice President and Chief Financial [...]

Evolus Appoints Ashwin K. Agarwal as Vice President, Finance, Investor Relations and Treasury

05/09/2018 - 14:01

IRVINE, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the appointment of Ashwin K. Agarwal as Vice President, Finance, Investor [...]

Matinas BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

05/09/2018 - 14:00

Presentation with live audio webcast on Thursday, September 6th at 5:05 PM ET BEDMINSTER, N.J., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical [...]

Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference

05/09/2018 - 14:00

LAKE FOREST, Ill., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior [...]

AIT Therapeutics Announces $526,500 Sale of Common Stock To Institutional Investor, Lincoln Park Capital Fund

05/09/2018 - 14:00

GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 05, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB:AITB) (“AIT Therapeutics or the “Company”), a clinical-stage medical device and biopharmaceutical company focused [...]

Progressive Care Inc. CEO to Speak at First US FlyPharma Conference in Miami, Fla.

05/09/2018 - 14:00

MIAMI, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that the company will be attending and speaking at the [...]

Yield10 Bioscience Reports Promising Seed Yield Results for Novel Yield Trait C3004 in Growth Chamber Studies in Camelina

05/09/2018 - 14:00

--Fast-Tracking Deployment of C3004 Trait into Canola and Soybean WOBURN, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change [...]

Inovio Doses 1st Subject in Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection

05/09/2018 - 14:00

PLYMOUTH MEETING, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today announced the dosing of the first subject with its vaccine to prevent infection from the deadly MERS [...]

Tetra Bio-Pharma Secures CBD Supply Agreement for Genacol Partnership

05/09/2018 - 14:00

ORLEANS, Ontario, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that it has secured a [...]

WishBone Medical, Inc. announces new AlloMate Bone Pin System

05/09/2018 - 14:00

WARSAW, Ind., Sept. 05, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. announces the official launch of the single-use, sterile packed AlloMate Bone Pin System for the maintenance of alignment and fixation of bone [...]

Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma

05/09/2018 - 14:00

EXTON, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]

DiaMedica Therapeutics Announces the Appointment of Dr. Harry Alcorn Jr. as Chief Medical Officer

05/09/2018 - 14:00

MINNEAPOLIS, Sept. 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ” and “ DiaMedica ”) (TSX-V:DMA) (OTCQB:DMCAF) announces the recent appointment of Harry Alcorn Jr. Pharm.D. as Chief Medical [...]

Palvella Therapeutics Appoints Rare Disease Senior Executive Elaine J. Heron, PhD to Board of Directors

05/09/2018 - 14:00

Dr. Heron Adds Deep Expertise in Orphan Drug Development and Commercialization Wayne, PA, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing [...]